🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Malignant Female Reproductive System Neoplasm

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Improve Cancer-related Cognitive Impairment NCT05864274NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: Cognitive training application Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site📍 San Francisco Rahul Aggarwal · Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries NCT06816836n/a1 site📍 Kolkata Tata Medical Center · Tests: Bed Side ultrasound guided muscle mass estimation of lower extremity Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer NCT06040970Phase 1, Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Sacituzumab, Cisplatin Pilot Observational Study of an Integrative Cure Stay Program NCT07398079n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: Integrative Cure Stay, Matched Control Group Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy NCT04957511n/a1 site📍 Orlando Viome DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Atezolizumab Spatially Fractionated Radiation Treatment for Gynaecological Cancers NCT06644846NA1 site📍 Navi Mumbai Tata Memorial Hospital · Tests: Spatially fractionated radiation therapy Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment NCT05562778NA4 sites📍 Brooklyn📍 New York📍 New York Weill Medical College of Cornell University · Tests: Chatbot Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) NCT05407987Phase 31 site📍 Calgary AHS Cancer Control Alberta · Tests: Ferric derisomaltose, Placebo BOLSTER: Learning New Skills to Thrive NCT06936878NA2 sites📍 Boston📍 Houston Dana-Farber Cancer Institute · Tests: BOLSTER Program A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites📍 Duarte📍 Los Angeles📍 San Francisco Nurix Therapeutics, Inc. · Tests: NX-1607, Paclitaxel Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers NCT05049538n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Liquid Biopsy, Pap Smear Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract NCT05478876NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: carbon ion radiation therapy CIRT Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies NCT05457595NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: carbon ion radiation therapy Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers NCT07731880n/a1 site📍 Seattle Fred Hutchinson Cancer Center Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NCT07483658NA4 sites📍 Gatineau📍 Montreal📍 Montreal CHU de Quebec-Universite Laval · Tests: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radi… DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites📍 Anderlecht📍 Ghent📍 Wilrijk European Organisation for Research and Treatment of Cancer … · Tests: Stereotactic body radiotherapy, Palliative RT Advanced Pelvic Surgical Oncology Database - Prospective Observational Study NCT05696002n/a1 site📍 Glasgow Glasgow Royal Infirmary First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors NCT05768139Phase 1, Phase 265 sites📍 Los Angeles📍 San Francisco📍 Aurora Eli Lilly and Company · Tests: STX-478, Fulvestrant, Ribociclib, Palbociclib, Letrozole Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer NCT04530890NA1 site📍 Poitiers Poitiers University Hospital · Tests: Blood samples A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Engineering Tumor Infiltrating Lymphocytes Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients NCT05738252n/a4 sites📍 Hamilton📍 Mississauga📍 Toronto Population Health Research Institute · Tests: Clinical Frailty Scale, Frailty Phenotype Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407NA1 site📍 Beijing Peking University People's Hospital · Tests: Indication-extended Fertility-sparing Therapy Distance-Based Exercise to Preserve Function and Prevent Disability NCT07059884NA23 sites📍 Dublin📍 Fremont📍 Fresno Alliance for Clinical Trials in Oncology · Tests: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Exercise Intervention, Accelerometry
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy